Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end-stage liver disease (NACSELD) experience
Top Cited Papers
Open Access
- 13 July 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 56 (6), 2328-2335
- https://doi.org/10.1002/hep.25947
Abstract
Bacterial infections are an important cause of mortality in cirrhosis, but there is a paucity of multicenter studies. The aim was to define factors predisposing to infection‐related mortality in hospitalized patients with cirrhosis. A prospective, cohort study of patients with cirrhosis with infections was performed at eight North American tertiary‐care hepatology centers. Data were collected on admission vitals, disease severity (model for endstage liver disease [MELD] and sequential organ failure [SOFA] scores), first infection site, type (community‐acquired, healthcare‐associated [HCA] or nosocomial), and second infection occurrence during hospitalization. The outcome was mortality within 30 days. A multivariate logistic regression model predicting mortality was created. 207 patients (55 years, 60% men, MELD 20) were included. Most first infections were HCA (71%), then nosocomial (15%) and community‐acquired (14%). Urinary tract infections (52%), spontaneous bacterial peritonitis (SBP, 23%) and spontaneous bacteremia (21%) formed the majority of the first infections. Second infections were seen in 50 (24%) patients and were largely preventable: respiratory, including aspiration (28%), urinary, including catheter‐related (26%), fungal (14%), and Clostridium difficile (12%) infections. Forty‐nine patients (23.6%) who died within 30 days had higher admission MELD (25 versus 18, P < 0.0001), lower serum albumin (2.4 g/dL versus 2.8 g/dL, P = 0.002), and second infections (49% versus 16%, P < 0.0001) but equivalent SOFA scores (9.2 versus 9.9, P = 0.86). The case fatality rate was highest for C. difficile (40%), respiratory (37.5%), and spontaneous bacteremia (37%), and lowest for SBP (17%) and urinary infections (15%). The model for mortality included admission MELD (odds ratio [OR]: 1.12), heart rate (OR: 1.03) albumin (OR: 0.5), and second infection (OR: 4.42) as significant variables. Conclusion: Potentially preventable second infections are predictors of mortality independent of liver disease severity in this multicenter cirrhosis cohort. (HEPATOLOGY 2012;56:2328–2335)Keywords
This publication has 23 references indexed in Scilit:
- Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective studyHepatology, 2011
- Hospital-Acquired Infections Due to Gram-Negative BacteriaNew England Journal of Medicine, 2010
- Clostridium difficile Is Associated With Poor Outcomes in Patients With Cirrhosis: A National and Tertiary Center PerspectiveAmerican Journal Of Gastroenterology, 2010
- The systemic inflammatory response syndrome in cirrhotic patients: Relationship with their in-hospital outcomeJournal of Hepatology, 2009
- Strategies to Prevent Surgical Site Infections in Acute Care HospitalsInfection Control & Hospital Epidemiology, 2008
- Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care HospitalsInfection Control & Hospital Epidemiology, 2008
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008
- Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002Public Health Reports®, 2007
- The economic impact of infection control: Making the business case for increased infection control resourcesAmerican Journal of Infection Control, 2005
- Bacterial infection in patients with advanced cirrhosis: a multicentre prospective studyDigestive and Liver Disease, 2001